Shandong Realcan Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio
Shandong Realcan Pharmaceutical Co Ltd cash flow-to-debt ratio. Shandong Realcan Pharmaceutical Co Ltd (002589) has a Cash Flow-to-Debt Ratio of 0.00x as of September 2025, meaning its operating cash flow of CN¥-15.60 Million could theoretically repay 0% of its total liabilities (CN¥9.87 Billion) in one year. Check Shandong Realcan Pharmaceutical Co Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Shandong Realcan Pharmaceutical Co Ltd (2008–2025)
Cash flow-to-debt ratio of Shandong Realcan Pharmaceutical Co Ltd from 2008 to 2025. Historical debt coverage capacity for Shandong Realcan Pharmaceutical Co Ltd across 18 annual periods. Check earnings quality score of Shandong Realcan Pharmaceutical Co Ltd to evaluate the quality of earnings relative to operating cash generation.
Shandong Realcan Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio by Year (2008–2025)
Shandong Realcan Pharmaceutical Co Ltd cash flow-to-debt ratio by year from 2008 to 2025. Year-by-year debt coverage analysis for Shandong Realcan Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Shandong Realcan Pharmaceutical Co Ltd (002589) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | CN¥13.76 Million | CN¥8.95 Billion | ▼ -90.1% |
| 2024 | 0.02x | CN¥160.44 Million | CN¥10.32 Billion | ▲ +108.8% |
| 2023 | 0.01x | CN¥82.47 Million | CN¥11.07 Billion | ▼ -82.1% |
| 2022 | 0.04x | CN¥523.07 Million | CN¥12.58 Billion | ▲ +56.8% |
| 2021 | 0.03x | CN¥442.95 Million | CN¥16.70 Billion | ▲ +38.3% |
| 2020 | 0.02x | CN¥414.96 Million | CN¥21.65 Billion | ▼ -79.7% |
| 2019 | 0.09x | CN¥2.09 Billion | CN¥22.21 Billion | ▲ +1200.2% |
| 2018 | -0.01x | CN¥-201.66 Million | CN¥23.53 Billion | ▲ +93.9% |
| 2017 | -0.14x | CN¥-2.42 Billion | CN¥17.31 Billion | ▲ +35.1% |
| 2016 | -0.22x | CN¥-1.76 Billion | CN¥8.15 Billion | ▼ -152.5% |
| 2015 | -0.09x | CN¥-466.26 Million | CN¥5.46 Billion | ▼ -101.2% |
| 2014 | -0.04x | CN¥-163.62 Million | CN¥3.85 Billion | ▲ +56.6% |
| 2013 | -0.10x | CN¥-274.46 Million | CN¥2.80 Billion | ▼ -26.5% |
| 2012 | -0.08x | CN¥-170.52 Million | CN¥2.20 Billion | ▲ +77.2% |
| 2011 | -0.34x | CN¥-475.03 Million | CN¥1.40 Billion | ▼ -668.9% |
| 2010 | 0.06x | CN¥70.56 Million | CN¥1.18 Billion | ▼ -21.7% |
| 2009 | 0.08x | CN¥61.38 Million | CN¥805.78 Million | ▲ +192.2% |
| 2008 | -0.08x | CN¥-49.88 Million | CN¥603.64 Million | — |